FDA Adverse Event Injury Summary report: N

JUVEDERM VOLUMA WITH LIDOCAINE 1ML

MDR report key: 15486184 · Received September 26, 2022

Report

Report Number
3005113652-2022-00617
Event Type
Injury
Date Received
September 26, 2022
Date of Event
July 18, 2022
Report Date
October 14, 2022
Manufacturer
ALLERGAN (PRINGY)
Product Code
LMH
PMA / PMN Number
P110033
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
IN
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

CLARIFICATION: THE FILLER WAS INJECTED INTO THE PATIENT AND IS NOT ACCESSIBLE FOR RETURN. THE SYRINGE WAS NOT RETURNED FOR EVALUATION. FURTHER INFORMATION REGARDING EVENT, PRODUCT, OR PATIENT DETAILS HAS BEEN REQUESTED. NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME. THE EVENT IS A PHYSIOLOGICAL COMPLICATION AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT. THE EVENT OF TACHYCARDIA, DEEMED NOT DEVICE RELATED IS CONSIDERED AN UNEXPECTED ADVERSE DRUG EXPERIENCE.

Additional Manufacturer Narrative · 0

A REVIEW OF THE DEVICE HISTORY RECORD HAS BEEN COMPLETED. NO DEVIATIONS OR NON-CONFORMANCES NOTED. ADDITIONAL, CHANGED, AND/OR CORRECTED DATA: H.6.

Description of Event or Problem · 0

HEALTHCARE PROFESSIONAL REPORTED ¿PATIENT IS GETTING SWELLING EVERY WEEK ON ALL THE PARTS WHERE FILLER WAS INJECTED¿ SIX DAYS AFTER THEY WERE INJECTED IN CK1 AND 2, JW 1, 2 AND 3, AND C1 WITH TWO SYRINGES OF JUVÉDERM® VOLUMA¿ WITH LIDOCAINE. PATIENT WAS TREATED WITH STEROIDS JUST AFTER PROCEDURE BUT HAS TO STOPPED THE TREATMENT DUE TO TACHYCARDIA, DEEMED NOT RELATED TO THE DEVICE. AT SOME POINTS, SWELLING REDUCES THERE BUT AGAIN IN A WEEK'S TIME ANTHER POINT SWELLS UP. PATIENT WAS TREATED WITH "HYALASED THE AREAS ALMOST 6-7 TIMES WITH IMPROVEMENT AFTER EACH SESSION OF HYALASE.¿ EVENT IS ONGOING AT THIS TIME.

Description of Event or Problem · 0

HEALTHCARE PROFESSIONAL REPORTED ¿PATIENT IS GETTING SWELLING EVERY WEEK ON ALL THE PARTS WHERE FILLER WAS INJECTED¿ SIX DAYS AFTER THEY WERE INJECTED IN CK1 AND 2, JW 1, 2 AND 3, AND C1 WITH TWO SYRINGES OF JUVÉDERM® VOLUMA¿ WITH LIDOCAINE. PATIENT WAS TREATED WITH STEROIDS JUST AFTER PROCEDURE BUT HAS TO STOPPED THE TREATMENT DUE TO TACHYCARDIA, DEEMED NOT RELATED TO THE DEVICE. AT SOME POINTS, SWELLING REDUCES THERE BUT AGAIN IN A WEEK'S TIME ANTHER POINT SWELLS UP. PATIENT WAS TREATED WITH "HYALASED THE AREAS ALMOST 6-7 TIMES WITH IMPROVEMENT AFTER EACH SESSION OF HYALASE.¿ EVENT IS ONGOING AT THIS TIME.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2935404 JUVEDERM VOLUMA WITH LIDOCAINE 1ML IMPLANT, DERMAL, FOR AESTHETIC USE LMH ALLERGAN (PRINGY) VB20B10954

Patients

Seq Age Sex Outcome Treatment
1 48 YR Female